De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

OUE Healthcare Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Kum Meng Yet

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	5.7yrs
Eigendom CEO	n/a
Management gemiddelde ambtstermijn	4.3yrs
Gemiddelde ambtstermijn bestuur	6.5yrs

Recente managementupdates

Recent updates

CEO

Kum Meng Yet (53 yo)

5.7yrs

Tenure

Mr. Kum Meng Yet serves as Chief Executive Officer and Executive Director at OUE Healthcare Limited (formerly known as OUE Lippo Healthcare Limited) since February 28, 2019. Mr. Yet served as Chief Financi...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kum Meng Yet	CEO & Executive Director	5.7yrs	geen gegevens	geen gegevens
Julie McCaughan	Chief Operating Officer	less than a year	geen gegevens	geen gegevens
Sau Yan Yiu	Chief Technology Officer	7.2yrs	geen gegevens	geen gegevens
Tun Foo Chong	Company Secretary	2.8yrs	geen gegevens	geen gegevens

4.3yrs

Gemiddelde duur

Ervaren management: Het managementteam van 5WA wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kum Meng Yet	CEO & Executive Director	5.7yrs	geen gegevens	geen gegevens
Yi Shyan Lee	Non-Independent Non-Executive Chairman	7.3yrs	S$112.50k	geen gegevens
Kian Hin Sho	Independent Non-Executive Director	7.8yrs	S$118.75k	geen gegevens
Eng Kiat Tay	Independent Non-Executive Director	7.8yrs	S$81.25k	geen gegevens
Chade Phang Tan	Lead Independent Non-Executive Director	7.8yrs	S$126.25k	geen gegevens
Abram Melkyzedeck Suhardiman	Non-Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens
Usha Ranee Chandradas	Independent Non-Executive Director	2.9yrs	S$68.75k	geen gegevens
Takeshi Seo	Non-Independent Non-Executive Director	less than a year	geen gegevens	geen gegevens

6.5yrs

Gemiddelde duur

48yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 5WA wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.5 jaar).

OUE Healthcare Beheer

Beheer criteriumcontroles 2/4

Belangrijke informatie

Recente managementupdates

OUE Healthcare Limited Appoints Julie Carlene Mccaughan as Chief Operating Officer

OUE Healthcare Limited, Annual General Meeting, Apr 25, 2024

Oue Healthcare Limited Appoints Takeshi Seo as Non-Independent and Non-Executive Director, Member of Nominating and Remuneration Committee, Effective April 9, 2024

OUE Healthcare Limited Announces Board Changes

OUE Lippo Healthcare Limited, Annual General Meeting, Apr 27, 2022

OUE Lippo Healthcare Limited Announces Changes to the Composition of the Board and Board Committees

Recent updates

New minor risk - Share price stability

First half 2024 earnings released: S$0.001 loss per share (vs S$0 in 1H 2023)

New minor risk - Share price stability

New minor risk - Share price stability

OUE Healthcare Limited Appoints Julie Carlene Mccaughan as Chief Operating Officer

OUE Healthcare Limited, Annual General Meeting, Apr 25, 2024

Oue Healthcare Limited Appoints Takeshi Seo as Non-Independent and Non-Executive Director, Member of Nominating and Remuneration Committee, Effective April 9, 2024

Full year 2023 earnings released: EPS: S$0.002 (vs S$0.001 in FY 2022)

OUE Healthcare Limited to Report Second Half, 2023 Results on Feb 29, 2024

New minor risk - Financial data availability

OUE Healthcare Limited Announces Board Changes

New minor risk - Market cap size

First half 2023 earnings released: EPS: S$0 (vs S$0.002 in 1H 2022)

Full year 2022 earnings released: EPS: S$0.001 (vs S$0.025 in FY 2021)

First half 2022 earnings released

Full year 2021 earnings released: EPS: S$0.025 (vs S$0.022 loss in FY 2020)

OUE Lippo Healthcare Limited, Annual General Meeting, Apr 27, 2022

OUE Lippo Healthcare Limited Announces Changes to the Composition of the Board and Board Committees

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

OUE Lippo Healthcare Limited to Report Fiscal Year 2021 Results on Feb 15, 2022

First Real Estate Investment Trust (SGX:AW9U) entered into a sale and purchase agreement to acquire OUELH Japan Medical Facilities Pte. Ltd. from OUE Lippo Healthcare Limited (Catalist:5WA) for SGD 163.2 million.

Chief Financial Officer Yen Shan Yik has left the company

Director Chade Phang Tan has joined 5th company board

Company Secretary Fazilah Abdul Rahman has left the company

OUE Lippo Healthcare Limited Judgment in Relation to CA113, CA132 & CA135- Receipt of Letter of Demand from Value Monetization Iii

Full year 2020 earnings released: S$0.022 loss per share (vs S$0.001 profit in FY 2019)

OUE Lippo Healthcare Limited has completed a Follow-on Equity Offering in the amount of SGD 158.212445 million.

OUE Lippo Healthcare Limited to Report Fiscal Year 2020 Results on Feb 23, 2021

Full year 2020 earnings released

OUE Lippo Healthcare Limited Announces Strategic Partnership with China Merchants Group

Oue Lippo Healthcare Limited Announces Status Update in Relation to Suit No. 441 of 2016

CEO

Tenure

Leiderschapsteam

Gemiddelde duur

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd